Obalon Therapeutics | 8-K: Current report
Obalon Therapeutics | 4: Statement of changes in beneficial ownership of securities
Obalon Therapeutics | 4: Statement of changes in beneficial ownership of securities
Obalon Therapeutics | 424B3: Prospectus
Obalon Therapeutics | 4: Statement of changes in beneficial ownership of securities
Obalon Therapeutics | 4: Statement of changes in beneficial ownership of securities
Obalon Therapeutics | 4: Statement of changes in beneficial ownership of securities
Obalon Therapeutics | 4: Statement of changes in beneficial ownership of securities
Obalon Therapeutics | 4: Statement of changes in beneficial ownership of securities
Obalon Therapeutics | 4: Statement of changes in beneficial ownership of securities
Obalon Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Obalon Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Obalon Therapeutics | 4: Statement of changes in beneficial ownership of securities
Obalon Therapeutics | 4: Statement of changes in beneficial ownership of securities
Obalon Therapeutics | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Obalon Therapeutics | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)
Obalon Therapeutics | 4: Statement of changes in beneficial ownership of securities
Obalon Therapeutics | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
Obalon Therapeutics | 3: Initial statement of beneficial ownership of securities
Obalon Therapeutics | 3: Initial statement of beneficial ownership of securities
No Data